Scholarly Index
Jeffrey A. Zonder
The Barbara Ann Karmanos Cancer Institute; 12,117 total citations; 337 total publications; best world rank #184
The Barbara Ann Karmanos Cancer Institute
12,117Total citations
337Total publications
50H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 265 | US 132 | 98.38 |
| Protein Degradation and Inhibitors | Lifetime | 289 | US 165 | 97.68 |
| Peptidase Inhibition and Analysis | Lifetime | 936 | US 412 | 97.14 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 570 | US 235 | 94.34 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 184 | US 99 | 97.41 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 468 | US 155 | 93.21 |
| Protein Degradation and Inhibitors | 2021-2025 | 347 | US 163 | 92.98 |
| Peptidase Inhibition and Analysis | 2021-2025 | 825 | US 197 | 87.42 |
| Cancer Treatment and Pharmacology | 2021-2025 | 995 | US 320 | 83.32 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 807 | US 268 | 78.17 |